Search results

Results 1 - 10 of 58 for parturition within all areas of the EPA. Only web pages are included. Search all document formats.

Show 102550100 per page  

EPA - Endocrine | 06915-02 Lindane Modification of Uterine Muscle03-02-2006

... inhibition of gap junctional communication relaxes uterine muscle andinterferes with parturition... of the proposal are to: l) Characterize lindane's effects on parturition in rats; 2) Characterize lindane inhibition ofrat uterine contractility in ...

http://www.epa.gov/edrlupvx/inventory/NIEH-085.html (HTML)

White phosphorus (CASRN 7723-14-0) | IRIS | US EPA01-21-2010

... in the high-dose females, was attributed to difficulty during parturition, with 13 of 16 deaths occurring on days 21 or ...

http://www.epa.gov/IRIS/subst/0460.htm (HTML)

IRIS Summary of White phosphorus (CASRN 7723-14-0)01-21-2010

"This is a summary of information on White phosphorus (CASRN 7723-14-0) provided by the Integrated Risk Information System (IRIS)."

http://www.epa.gov/NCEA/iris/subst/0460.htm (HTML)

Tributyltin oxide (TBTO)(CASRN 56-35-9) | IRIS | US EPA07-09-2009

... and F1 adults included clinical observations, dates of mating and parturition, gestation duration, maternal behavioral abnormalities, organ weights, gross pathology, histopathology ...

http://www.epa.gov/ncea/iris/subst/0349.htm (HTML)

White phosphorus (CASRN 7723-14-0) | IRIS | US EPA07-09-2009

... in the high-dose females, was attributed to difficulty during parturition, with 13 of 16 deaths occurring on days 21 or ...

http://www.epa.gov/ncea/iris/subst/0460.htm (HTML)

Tributyltin oxide (TBTO)(CASRN 56-35-9) | IRIS | US EPA01-28-2010

A high incidence of early parturitions was observed in all dose groups (19.2, 12.0 , 8.3 and ... There was also a change in delayed parturitions (0, 16.0, 27.8 and 0%, respectively, vs.

http://www.epa.gov/IRIS/subst/0349.htm (HTML)

IRIS Summary of Tributyltin oxide (TBTO) (CASRN 56-35-9)01-28-2010

"This is a summary of information on Tributyltin oxide (TBTO) (CASRN 56-35-9) provided by the Integrated Risk Information System (IRIS)."

http://www.epa.gov/NCEA/iris/subst/0349.htm (HTML)

Mirex (CASRN 2385-85-5) | IRIS | US EPA01-21-2010

... specified) from day 4 of gestation through day 34 post-parturition... Part I: Pre-parturition observations of the cardiovascular system.

http://www.epa.gov/IRIS/subst/0251.htm (HTML)

IRIS Summary of Mirex (CASRN 2385-85-5)01-21-2010

"This is a summary of information on Mirex (CASRN 2385-85-5) provided by the Integrated Risk Information System (IRIS)."

http://www.epa.gov/NCEA/iris/subst/0251.htm (HTML)

EPA - Endocrine | Drug Metabolism: Susceptibility to Delayed Teratogenesis03-02-2006

... mammal remains susceptible to the teratogenic effects of aternally administered drugs from conception, through fetal development, parturition and during nursing.

http://www.epa.gov/edrlupvx/inventory/NICH-001.html (HTML)

[Prev] 1 2 3 4 5 6 [Next]